The RIFLE Score Increases the Accuracy of Outcome Prediction in Patients with Acute Respiratory Distress Syndrome Undergoing Open Lung Biopsy

Chang

The Annals of Thoracic Surgery

et al. 2015

Self Cite

Section: Commentcontrasting

confidence: 60%

Acute Respiratory Distress Syndrome With and Without Extracorporeal Membrane Oxygenation: A Score Matched Study

Chang

The Annals of Thoracic Surgery

et al. 2015

Self Cite

“…However, in the present study, the SOFA score was not affected by PMX-DHP. Other scoring systems could be useful to assess patients with IP; for example, the RIFLE score predicts the outcome of ARDS patients who undergo open lung biopsy [37]. The mortality rates for patients with rapidly progressive IP in 3 recent reports [18,19,21] were 33.3, 50 and 60%, respectively.…”

Section: Discussionmentioning

confidence: 99%

Direct Hemoperfusion Using Immobilized Polymyxin B in Patients with Rapidly Progressive Interstitial Pneumonias: A Retrospective Study

et al. 2010

Background: Rapidly progressive interstitial pneumonia (IP), including acute exacerbation of IP, has a high mortality rate. Direct hemoperfusion with a polymyxin B-immobilized fiber column (PMX-DHP) was recently identified as an effective treatment for sepsis-associated acute respiratory distress syndrome. However, little is known about the effectiveness of PMX-DHP for rapidly progressive IP. Objectives: The present study investigates whether PMX-DHP is safe and effective against rapidly progressive IP. Methods: We retrospectively examined the effects of PMX-DHP in 33 consecutive patients with rapidly progressive IP who were resistant to steroid pulse therapy. Patients were hospitalized at Nagasaki University Hospital between 2006 and 2009. Results: Seventy-two hours after PMX-DHP, the arterial oxygen tension/inspiratory oxygen fraction ratio (median 127–153 mm Hg) had significantly improved. One week after PMX-DHP, the arterial oxygen tension/inspiratory oxygen fraction ratio (median 127–227 mm Hg), the alveolar-arterial difference of oxygen (median 371–177 mm Hg) and the number of positive criteria for systemic inflammatory response syndrome had significantly improved, despite the ineffectiveness of corticosteroid pulse therapy. The serum level of monocyte chemotactic protein 1 was significantly decreased immediately after PMX-DHP. Conclusions: PMX-DHP was safe and effective in improving oxygenation and systemic inflammatory response syndromein patients with rapidly progressive IP. The beneficialeffects of PMX-DHP may be at least partially due to the inhibition of monocyte activation.

“…Using retrospectively collected data, Lin et al [32] earlier reported that a maximum RIFLE (RIFLEmax) score on ICU days 1 and 3 and on the day of open lung biopsy (OLB) improves the accuracy of outcome prediction in ARDS patients undergoing OLB. To compare the predictive value of outcome scoring systems (APACHE IV, earlier APACHE models, SOFA, RIFLE criteria, Acute Lung Injury score) the authors further retrospectively abstracted data from the medical records of 135 critically ill ARDS patients [33] .…”

Section: Acute Respiratory Distress Syndromementioning

confidence: 99%

Acute kidney injury classification: AKIN and RIFLE criteria in critical patients

Lin

Chen

2012

WJCCM

Self Cite

Acute kidney injury (AKI) is a common and serious complication in critically ill patients. The mortality rate remains high despite improved renal replacement techniques. A possible cause of the high mortality rate is that intensive care unit patients tend to be older and more debilitated than before. Pathophysiological factors associated with AKI are also implicated in the failure of other organs, indicating that AKI is often part of a multiple organ failure syndrome. Until recently, there was a lack of consensus as to the best definition, characterization, and evaluation of acute renal failure. This lack of a standard definition has been a major impediment to progress in clinical and basic research. The introduction of the risk, injury, failure, loss, and end-stage kidney disease criteria and the modified version proposed by the Acute Kidney Injury Network have increased the conceptual understanding of AKI syndrome, and these criteria have been successfully tested in clinical studies. This article reviews current findings concerning the application of these criteria for assessing epidemiology and predicting outcome in specific homogeneous critically ill patient groups.